PATENT CLAIM ANALYSIS

Application Number: 15762508
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides miR-19 modulators and uses thereof, such as for promoting angiogenesis and/or wound healing with miR-19 inhibitors alone or in combination with other agents. The present invention also provides methods of treating or preventing arterial and cardiac conditions with a miR-19 inhibitor. Also provided are oligonucleotides with chemical motifs that are miR-19 inhibitors, and methods of using the oligonucleotides for inhibiting the function or activity of miR-19 in a subject in need thereof.

Claim (Index 35):
The method of any one of  claims 32 - 34 , wherein the subject suffers from ischemia, myocardial infarction, chronic ischemic heart disease, peripheral or coronary artery occlusion, ischemic infarction, stroke, atherosclerosis, acute coronary syndrome, coronary artery disease, carotid artery disease, diabetes, chronic wound(s), peripheral vascular disease or peripheral artery disease.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15878176', '15154711', '13924340', '15714671', '13327507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8275829958587088
- 35 USC 102 Novelty (BERT): 0.5401716443615253
- Combined Prediction Score: 0.7988418607089904
- Mean Citation Score: 399.333386
- Max Citation Score: 468.14435
- Similarity Product: 197.8042208676815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test